Invention Grant
- Patent Title: Chromatography ligand comprising domain C from Staphylococcus aureus protein A for antibody isolation
-
Application No.: US17107600Application Date: 2020-11-30
-
Publication No.: US11517879B2Publication Date: 2022-12-06
- Inventor: Martin Hall , Sture Larsson , Andreas Muranyi , Gustav Rodrigo , Jinyu Zou , Per-Mikael Aberg
- Applicant: Cytiva Bioprocess R&D AB
- Applicant Address: SE Uppsala
- Assignee: Cytiva Bioprocess R&D AB
- Current Assignee: Cytiva Bioprocess R&D AB
- Current Assignee Address: SE Uppsala
- Agency: Culhane Meadows, PLLC
- Agent Jeff B. Vockrodt
- Priority: SE0602061-4 20060929
- Main IPC: B01J20/24
- IPC: B01J20/24 ; B01D15/38 ; B01J20/286 ; C07K1/22 ; B01J20/32 ; C07K14/31 ; C07K16/00 ; C07K17/00 ; B01J20/28 ; B01J20/285 ; B01J20/289 ; C07K17/10

Abstract:
The present invention relates to a chromatography ligand, which comprises Domain C from Staphylococcus protein A (SpA), or a functional fragment or variant thereof. The chromatography ligand presents an advantageous capability of withstanding harsh cleaning in place (CIF) conditions, and is capable of binding Fab fragments of antibodies. The ligand may be provided with a terminal coupling group, such as arginine or cysteine, to facilitate its coupling to an insoluble carrier such as beads or a membrane. The invention also relates process of using the ligand in isolation of antibodies, and to a purification protocol which may include washing steps and/or regeneration with alkali.
Public/Granted literature
- US20210291143A1 CHROMATOGRAPHY LIGAND COMPRISING DOMAIN C FROM STAPHYLOCOCCUS AUREUS PROTEIN A FOR ANTIBODY ISOLATION Public/Granted day:2021-09-23
Information query